Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

prognosis

  • Open Access
    TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis
    GWAN HEE HAN, HEE YUN, JOON-YONG CHUNG, JAE-HOON KIM and HANBYOUL CHO
    Cancer Genomics & Proteomics November 2022, 19 (6) 692-702; DOI: https://doi.org/10.21873/cgp.20352
  • Open Access
    Identification of a Novel Long Non-coding RNA, lnc-ATMIN-4:2, and its Clinicopathological and Prognostic Significance in Advanced Gastric Cancer
    EOJIN KIM, HYUNJIN KIM, MIN-KYUNG YEO, CHUL HWAN KIM, JOO YOUNG KIM, SUNGSOO PARK, HYUN-SOO KIM and YANG-SEOK CHAE
    Cancer Genomics & Proteomics November 2022, 19 (6) 761-772; DOI: https://doi.org/10.21873/cgp.20358
  • Open Access
    Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA
    Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
  • Open Access
    Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA
    Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
  • Open Access
    Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA
    Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
  • Open Access
    Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA
    Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
  • Open Access
    Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA
    Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
  • Open Access
    Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA
    Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
  • Open Access
    Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA
    Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340
  • Open Access
    Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas
    PEETER KARIHTALA, KATJA PORVARI and OUTI KILPIVAARA
    Cancer Genomics & Proteomics September 2022, 19 (5) 556-569; DOI: https://doi.org/10.21873/cgp.20340

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 490
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire